Skip to content
10-Q

Quarterly Report

Oric Pharmaceuticals, Inc. ORIC

0000950170-25-063564

← back to feed
Filed
May 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 28, 2025 71.09M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $17.62M
Current Liabilities Q1 2025 · Dec 31, 2024 $24.85M
Total Liabilities Q1 2025 · Mar 31, 2025 $23.12M
Total Liabilities Q1 2025 · Dec 31, 2024 $31.02M
Current Assets Q1 2025 · Mar 31, 2025 $211.43M
Current Assets Q1 2025 · Dec 31, 2024 $262.25M
Total Assets Q1 2025 · Mar 31, 2025 $242.86M
Total Assets Q1 2025 · Dec 31, 2024 $274.14M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $59.41M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $56.36M
Shares Diluted Q1 2025 · Mar 31, 2024 67.35M sh
Capex Q1 2025 · Mar 31, 2024 $218K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$30.19M
Stockholders Equity Q1 2025 · Mar 31, 2024 $328.65M
Stockholders Equity Q1 2025 · Dec 31, 2023 $224.09M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.37
Eps Basic Q1 2025 · Mar 31, 2024 −$0.37
Sga Expense Q1 2025 · Mar 31, 2024 $7.03M
Net Income Q1 2025 · Mar 31, 2024 −$25.01M
Operating Income Q1 2025 · Mar 31, 2024 −$28.99M